Search Results

Researchers at the Crick, King’s College London and Guy's and St Thomas' NHS Foundation Trust have conducted a highly detailed analysis of the composition of immune cells in the blood of patients with COVID-19, revealing new aspects of how SARS-Cov-2 causes disease.

Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by UCL and the Francis Crick Institute.

DeepMind’s AlphaFold system has been used to produce structural predictions of understudied proteins of SARS-CoV-2, the virus that causes COVID-19.

Researchers at the Francis Crick Institute are taking part in a new national research project to study the effects of emerging SARS-CoV-2 variants. 

Researchers at the Crick have characterised the structure of the SARS-CoV-2 spike protein as well as its most similar relative in a bat coronavirus. The structures provide clues about how the spike evolved and could help inform vaccine design. 

Katie Bentley's group are working with NHSx to model how Covid-19 spreads within hospitals and communities. We caught up with Katie to find out more about it.

The Crick, the UK’s largest discovery biomedical research lab, has offered to support the Government’s efforts to tackle the spread of COVID-19.

The Crick’s George Kassiotis answers some of the key questions about antibody testing.

What’s it like to drop everything and completely change your research focus? Hear from postdoc Rachel Ulferts on how it feels to be part of the global group of scientists studying the virus.